Interleukin-2 signaling | R-HSA-451927 | 5.05 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
Cell Cycle | R-HSA-1640170 | 3.89 |
Developmental Biology | R-HSA-1266738 | 3.48 |
Switching of origins to a post-replicative state | R-HSA-69052 | 6.85 |
Metabolism of amino acids and derivatives | R-HSA-71291 | 5.4 |
Signaling by VEGF | R-HSA-194138 | 4.66 |
FCERI mediated MAPK activation | R-HSA-2871796 | 4.32 |
HIV Infection | R-HSA-162906 | 5.22 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
Cell Cycle Checkpoints | R-HSA-69620 | 5.64 |
Orc1 removal from chromatin | R-HSA-68949 | 6.85 |
p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.15 |
Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.56 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
Assembly of the pre-replicative complex | R-HSA-68867 | 6.92 |
Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.72 |
APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.81 |
beta-catenin independent WNT signaling | R-HSA-3858494 | 5.83 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.37 |
Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.65 |
Hedgehog ligand biogenesis | R-HSA-5358346 | 6.98 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.31 |
G1/S Transition | R-HSA-69206 | 6.21 |
TCF dependent signaling in response to WNT | R-HSA-201681 | 5.36 |
Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.96 |
SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.23 |
G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.08 |
FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.14 |
p53-Independent DNA Damage Response | R-HSA-69610 | 7.28 |
p53-Independent G1/S DNA damage checkpoint | R-HSA-69613 | 7.28 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.07 |
FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |
Immune System | R-HSA-168256 | 2.37 |
Frs2-mediated activation | R-HSA-170968 | 5.12 |
CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.34 |
Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.34 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | R-HSA-5362768 | 7.2 |
Signaling by Hedgehog | R-HSA-5358351 | 5.79 |
Vpu mediated degradation of CD4 | R-HSA-180534 | 7.31 |
SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.18 |
Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.45 |
Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.12 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.28 |
p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.15 |
FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.14 |
Cell Cycle, Mitotic | R-HSA-69278 | 4.16 |
FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.14 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.85 |
Interferon Signaling | R-HSA-913531 | 4.95 |
Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
Mitotic G1-G1/S phases | R-HSA-453279 | 5.91 |
Interleukin receptor SHC signaling | R-HSA-912526 | 5.09 |
Host Interactions of HIV factors | R-HSA-162909 | 5.99 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.34 |
Innate Immune System | R-HSA-168249 | 3.17 |
Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.25 |
Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.1 |
CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
Mitotic Anaphase | R-HSA-68882 | 5.46 |
SOS-mediated signalling | R-HSA-112412 | 5.15 |
Regulation of mitotic cell cycle | R-HSA-453276 | 6.61 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
Prolonged ERK activation events | R-HSA-169893 | 5.11 |
Signaling by Wnt | R-HSA-195721 | 4.79 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
GRB2 events in EGFR signaling | R-HSA-179812 | 5.15 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
DNA Replication | R-HSA-69306 | 6.25 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
Interferon alpha/beta signaling | R-HSA-909733 | 6.04 |
Axon guidance | R-HSA-422475 | 3.93 |
M/G1 Transition | R-HSA-68874 | 6.62 |
Signaling by Leptin | R-HSA-2586552 | 5.1 |
Programmed Cell Death | R-HSA-5357801 | 5.65 |
IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
M Phase | R-HSA-68886 | 4.87 |
IRS-mediated signalling | R-HSA-112399 | 4.87 |
Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
Disease | R-HSA-1643685 | 3.33 |
Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.37 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
Gene Expression | R-HSA-74160 | 2.72 |
Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
Antigen processing-Cross presentation | R-HSA-1236975 | 5.88 |
ER-Phagosome pathway | R-HSA-1236974 | 6.08 |
Stabilization of p53 | R-HSA-69541 | 7.28 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
Infectious disease | R-HSA-5663205 | 4.47 |
AUF1 (hnRNP D0) destabilizes mRNA | R-HSA-450408 | 7.23 |
GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.15 |
Signalling to RAS | R-HSA-167044 | 5.08 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.15 |
SHC1 events in EGFR signaling | R-HSA-180336 | 5.15 |
DNA Replication Pre-Initiation | R-HSA-69002 | 6.62 |
FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.14 |
APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.98 |
Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.94 |
SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.15 |
PCP/CE pathway | R-HSA-4086400 | 6.47 |
ARMS-mediated activation | R-HSA-170984 | 5.12 |
S Phase | R-HSA-69242 | 6.02 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.87 |
Hedgehog 'on' state | R-HSA-5632684 | 6.62 |
Signalling to ERKs | R-HSA-187687 | 5.04 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.01 |
Separation of Sister Chromatids | R-HSA-2467813 | 5.55 |
Signaling by Interleukins | R-HSA-449147 | 4.71 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
NIK--noncanonical NF-kB signaling | R-HSA-5676590 | 7.12 |
Metabolism | R-HSA-1430728 | 2.34 |
Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.1 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.11 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.61 |
Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.1 |
TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.4 |
Hedgehog 'off' state | R-HSA-5610787 | 6.19 |
Signalling by NGF | R-HSA-166520 | 4.23 |
GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.1 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 |
Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.2 |
Regulation of DNA replication | R-HSA-69304 | 6.75 |
CDT1 association with the CDC6:ORC:origin complex | R-HSA-68827 | 7.12 |
RAF/MAP kinase cascade | R-HSA-5673001 | 5.15 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Synthesis of DNA | R-HSA-69239 | 6.37 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
Regulation of Apoptosis | R-HSA-169911 | 7.34 |
MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.54 |
Removal of licensing factors from origins | R-HSA-69300 | 6.81 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
degradation of AXIN | R-HSA-4641257 | 7.23 |
NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.87 |
Interleukin-3, 5 and GM-CSF signaling | R-HSA-512988 | 4.99 |
degradation of DVL | R-HSA-4641258 | 7.18 |
Regulation of RAS by GAPs | R-HSA-5658442 | 6.92 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.79 |
Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.64 |
Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.08 |
Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.19 |
Signal Transduction | R-HSA-162582 | 1.78 |
Ubiquitin-dependent degradation of Cyclin D1 | R-HSA-69229 | 7.34 |
Apoptosis | R-HSA-109581 | 5.68 |